Interestingly, the positive impact of NFE2L2 (gene encoding Nrf2) on the expression of the glutamate–cysteine ligase modifier subunit (GCLM) was observed only in the β-cells of individuals without type 2 diabetes, whereas no such effect was observed in diabetic samples from both datasets. The gene discussed is NFE2L2; the disease is type 2 diabetes mellitus.